Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 148.9B | 153.0B | 166.8B | 125.2B |
Cost of revenue | 53.0B | 35.8B | 41.5B | 32.9B |
Gross profit | 95.9B | 117.2B | 125.3B | 92.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 27.4B | 27.9B | 27.5B | 22.9B |
Other operating expenses | 29.1B | 42.3B | 42.6B | 31.1B |
Operating income | 8.3B | 19.4B | 29.9B | 15.4B |
Non operating interest income | ||||
Income | — | 1.4B | 750M | 1.2B |
Expense | 5.6B | 4.3B | 3.3B | 2.3B |
Other income expense | — | — | — | — |
Pretax income | 5.2B | 8.3B | 27.4B | 16.7B |
Tax provision | 1.7B | 3.8B | 2.9B | 2.7B |
Net income | 3.9B | 4.4B | 24.3B | 14.1B |
Basic EPS | — | 10.5 | 91.0 | 49.4 |
Diluted EPS | — | 10.5 | 91.0 | 49.4 |
Basic average shares | — | 254.8M | 254.8M | 254.8M |
Diluted average shares | — | 254.8M | 254.8M | 254.8M |
EBITDA | 23.3B | 30.7B | 39.2B | 26.7B |
Net income from continuing op. | 5.7B | 8.2B | 27.2B | 16.9B |
Minority interests | -1.5B | -1.7B | -1.2B | -1.5B |
Preferred stock dividends | 0 | 0 | 0 | 0 |